Nov 24, 2009 | Drugs.com
NUCRYST Announces Special Meeting of Shareholders
NUCRYST Pharmaceuticals Corp. announced today that a Special Meeting of Shareholders will be held on Monday, December 21, 2009.
Nucryst to Sell Operations and Assets to Smith & Nephew, Merge with Westaim
TORONTO a ' Nucryst Pharmaceuticals Corp. said Tuesday it has signed a deal to sell its all of its operations and assets including its nanocrystalline silver technology and merge the company with its majority shareholder.
Westaim Announces Amalgamation Agreement with NUCRYST Pharmaceuticals
The Westaim Corporation today announced the execution of an amalgamation agreement with NUCRYST Pharmaceuticals Corp.
Lou Schizas Published on Monday, Oct. 26, 2009 10:21AM EDT H i, What is happening with NCS TSX? It's still getting a five star rating but there seems to be no activity.
Also on Topix